Series of medicines running out of stock or suspended manufacturing due to problems in ingredient supply
With the unstable ingredient supply and manufacturing delays, there have been an endless number of medicines running temporary out-of-stock or suspended manufacturing.
According to the industry concerned, Sanofi-Aventis Korea’s Actonel 5mg recently went out of stock while Mucopect Tab(10 tablets...
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.